The first Covid-19 vaccines have changed biotech forever

For all the devastation the Covid-19 pandemic has caused, there is finally a bright spot: For the first time ever, drug companies created a vaccine against a novel pathogen within a year of its discovery—about a tenth of the time it usually takes.

These nucleic acid vaccines, which use cells’ existing infrastructure to manufacture their own medicine, appear poised to kickstart new era of rapid-response vaccine development. But their success wouldn’t have been possible without a supportive technology that allows the shots to reach the right destination in the body: tiny bits of fat called lipid nanoparticles.

Biotech is a silent exponential trend, read more.